Low-density lipoprotein-induced formation of nitric oxide by cultured vascular smooth muscle cells of the rat

European Journal of Clinical Investigation

Volumn 27, Issue 7, 1997, Pages 603-610

  Locher, R ^a   Suter, P M ^a   Weisser, B ^b   Vetter, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cell proliferation; Cyclic GMP; Endothelium dependent relaxing factor; Human low density lipoprotein; Rat

Indexed keywords

ARGININE; CITRULLINE; CYCLIC GMP; LOW DENSITY LIPOPROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRITE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030743778     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1540700.x     Document Type: Article

References (28)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JK. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-23.
2. Block LH, Knorr M, Vogt E et al. Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci USA 1988;85:885-9.
3. Sachinidis A, Locher R, Steiner A, Mengden T, Vetter W. Effect of low-density lipoprotein on intracellular calcium, intracellular pH and DNA synthesis in cultured vascular smooth muscle cells. J Hypertension 1989;7(suppl. 6):S116-17.
4. Iyengar R, Stuehr RJ, Marletta MA. Macrophage synthesis of nitrite, nitrate, and nitrosamines: precursor and role of the respiratory burst. Proc Natl Acad Sci USA 1987;84:6369-73.
5. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Taka Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1989;80:143-7.
6. Nakaki T, Yamamoto S, Nakayama M, Kato R. Inhibition by endothelium-derived relaxing factor and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Biosignalling Cardiac Vasc Syst 1989;66-9.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide. Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
8. Beasley D, Schwartz JH, Brenner BM. Interleukin-1β induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991;87:602-8.
9. Lowry OH, Rosebrough NH, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
10. Weisser B, Locher R, Mengden T, Vetter W. Oxidation of low densitv lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler Thromb 1992;12:231-6.
11. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981;25:373-8.
12. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA 1976;73:3178-82.
13. Nemecek GM, Coughli SR, Handley DH, Moskowitz M. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 1986;83:674-8.
14. Lamas S, Michel T, Brenner BM, Marsden PA. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-α. Am J Physiol 1991;30:C634-41.
15. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
16. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circ Res 1992;71:1088-100.
17. Mitchell JA, Kohlhaas KL, Matsumoto T et al. Induction of NADH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. Mol Pharmacol 1992;41:1163-8.
18. Beasley D, Eldridge M. Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994;266:R1197-203.
19. Kato J, Misko TP, Currie MG. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells. Eur J Pharmacol 1993;244:153-9.
20. Wileman SM, Mann GE, Baydoun AR. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Br J Pharmacol 1995;116:3243-50.
21. G-hydoxyl-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity. FEBS Lett 1994;341:203-7.
22. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-5.
23. Maggi E, Chiesa R, Melissano G et al. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994;14:1892-9.
24. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-18.
25. Oikawa S, Hori S, Sano R et al. Effect of low density lipoprotein on DNA synthesis of cultured human arterial smooth muscle cells. Atherosclerosis 1987;64:7-12.
26. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990;189:347-53.
27. Garg UC, Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
28. Nunokawa Y, Tanaka Y. Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 1992;188:409-15.